Pfizer Inc.
PFE
$25.74
$0.030.12%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 62.79B | 63.83B | 62.46B | 63.63B | 60.43B |
| Total Other Revenue | -- | 1.00M | 1.00M | 1.00M | 1.00M |
| Total Revenue | 62.79B | 63.83B | 62.46B | 63.63B | 60.43B |
| Cost of Revenue | 15.82B | 16.71B | 15.98B | 16.42B | 11.74B |
| Gross Profit | 46.97B | 47.13B | 46.49B | 47.21B | 48.69B |
| SG&A Expenses | 14.03B | 14.06B | 14.32B | 14.76B | 14.15B |
| Depreciation & Amortization | 5.00B | 5.09B | 5.19B | 5.29B | 5.19B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.06B | 46.15B | 46.01B | 47.29B | 41.68B |
| Operating Income | 17.73B | 17.69B | 16.46B | 16.34B | 18.75B |
| Income Before Tax | 9.15B | 10.53B | 7.39B | 8.02B | 3.90B |
| Income Tax Expenses | -685.00M | -235.00M | -510.00M | -28.00M | -402.00M |
| Earnings from Continuing Operations | 9.84K | 10.77K | 7.90K | 8.05K | 4.31K |
| Earnings from Discontinued Operations | 32.00M | 24.00M | 16.00M | 11.00M | -22.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -41.00M | -40.00M | -29.00M | -31.00M | -32.00M |
| Net Income | 9.83B | 10.75B | 7.88B | 8.03B | 4.25B |
| EBIT | 17.73B | 17.69B | 16.46B | 16.34B | 18.75B |
| EBITDA | 24.41B | 24.46B | 23.34B | 23.34B | 25.62B |
| EPS Basic | 1.73 | 1.89 | 1.39 | 1.42 | 0.75 |
| Normalized Basic EPS | 1.77 | 1.73 | 1.59 | 1.55 | 1.88 |
| EPS Diluted | 1.72 | 1.89 | 1.39 | 1.42 | 0.74 |
| Normalized Diluted EPS | 1.76 | 1.72 | 1.58 | 1.54 | 1.87 |
| Average Basic Shares Outstanding | 22.71B | 22.69B | 22.68B | 22.66B | 22.64B |
| Average Diluted Shares Outstanding | 22.83B | 22.82B | 22.81B | 22.80B | 22.75B |
| Dividend Per Share | 1.71 | 1.70 | 1.69 | 1.68 | 1.67 |
| Payout Ratio | 73.88% | 66.94% | 121.49% | 118.44% | 222.18% |